Global Markets for Surgical Ophthalmology in 2013: Forecasts Through 2017

  • April 2013
  • -
  • Life Science Intelligence (LSI)
  • -
  • 235 pages

The global market for products used in surgical ophthalmology-which includes diagnostic devices, surgical systems (e.g., lasers and phacoemulsification machines), intraocular lens (IOL) implants and disposables, accessories, and aftermarket revenues from services and parts-was valued at $7.4 billion in 2012. Growth is expected through 2017, when the market reaches $9.0 billion, due to continued penetration of the population with cataracts (especially in emerging markets) as a result of efforts among national and international organizations to reduce blindness. Refractive surgeries will also contribute to revenue growth, although economic headwinds in key national markets will limit the performance of these procedures. Other key trends, including pricing in local markets and product mix, will have key effects on competitive shares and product adoption.

Critical Issues Covered in this Report:

• The competitive landscape for these products in the U.S. and international markets;
• Discreet procedure volumes for ophthalmological surgeries, segmented by region; and
• Quantitative factors including pricing trends, licensing fees, and the revenue contribution from systems, disposables, services, and accessories.

Table Of Contents

Table of Contents

1. EXECUTIVE SUMMARY
• 1.1. The Global Market by Region
• 1.2. The Global Market by Product Segment
o 1.2.1. Competitive Analysis
• Exhibit 1-1: Global Market Forecast for Surgical Ophthalmology Products, 2009-2017
• Exhibit 1-2: Global Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017
• Exhibit 1-3: Global Market Forecast for Surgical Ophthalmology Products by Region, 2009-2017
• Exhibit 1-4: Global Market Forecast for Surgical Ophthalmology Products by Product Type, 2009-2017
• Exhibit 1-5: Global Supplier Shares, 2011 and 2012

2. OVERVIEW
• 2.1. Anatomy of the Human Eye
• 2.2. Blindness and Low Vision
• 2.3. Cataract Surgery
o 2.3.1. Phacoemulsification
o 2.3.2. Extracapsular Cataract Extraction
o 2.3.3. Intracapsular Cataract Extraction
• 2.4. Glaucoma Surgery
o 2.4.1. Surgeries to Reduce Production of Aqueous Humour
o 2.4.2. Surgeries to Improve the Flow of Aqueous Humour
o 2.4.2.1. Filtering Procedures
o 2.4.2.1.1. Penetrating Filtering Procedures
o 2.4.2.1.2. Non-Penetrating Filtering Procedures
o 2.4.2.2. Laser Trabeculoplasty
o 2.4.2.3. Iridotomy
o 2.4.2.4. Iridectomy
o 2.4.2.5. Glaucoma Implants
• 2.5. Vitreoretinal Surgery
• 2.6. Refractive Surgery
o 2.6.1. Flap Procedures
o 2.6.2. Surface Procedures
o 2.6.3. Corneal Incision Procedures
o 2.6.4. Phakic IOL Implantation
• Exhibit 2-1: General Types of Surgical Procedures for the Human Eye
• Exhibit 2-2: The Human Eye
• Exhibit 2-3: Causes of Blindness by Race/Ethnicity in the U.S., 2004
• Exhibit 2-4: Causes of Low Vision by Race/Ethnicity in the U.S., 2004
• Exhibit 2-5: Types of Glaucoma

3. OPHTHALMIC DIAGNOSTIC DEVICES
• 3.1. Slit Lamps
• 3.2. Ocular Tonometers
• 3.3. Corneal Pachymeters
• 3.4. Optical Coherence Tomography
• 3.5. Optical Biometers
• 3.6. Scanning Laser Polarimeters
• 3.7. Fundus Cameras
• 3.8. Wavefront Aberrometers
• Exhibit 3-1: Selected Slit Lamps
• Exhibit 3-2: Ocular Tonometry Methods
• Exhibit 3-3: Selected Clinical Studies that Examine the Effectiveness of Various Methods of Ocular Tonometry
• Exhibit 3-4: Selected Optical Tonometers
• Exhibit 3-5: Selected Clinical Studies that Examine the Effectiveness of Ultrasound Corneal Pachymetry
• Exhibit 3-6: Selected Ultrasound Corneal Pachymeters
• Exhibit 3-7: Selected Clinical Studies that Examine the Effectiveness of Optical Coherence Tomography
• Exhibit 3-8: Selected Optical Coherence Tomography Imaging Systems
• Exhibit 3-9: Selected Clinical Studies that Examine the Effectiveness of Optical Biometers
• Exhibit 3-10: Selected Biometry Systems
• Exhibit 3-11: Selected Clinical Studies that Examine the Effectiveness of Scanning Laser Polarimetry
• Exhibit 3-12: Selected Fundus Photography and Imaging Systems
• Exhibit 3-13: Selected Clinical Studies that Examine the Effectiveness of Wavefront Aberrometry
• Exhibit 3-14: Selected Wavefront Systems or Aberrometers

4. OPHTHALMIC SURGICAL SYSTEMS
• 4.1. Phacoemulsification Systems
o 4.1.1. Clinical Studies
o 4.1.2. Companies and Products
• 4.2. Ophthalmic Laser Systems
o 4.2.1. Clinical Studies
o 4.2.2. Companies and Products
o 4.2.2.1. Photocoagulating Lasers
o 4.2.2.2. Photodisrupting Lasers
o 4.2.2.3. Photoablating Lasers
o 4.2.2.4. Femtosecond Lasers
o 4.2.2.5. Combination or Multi-Modal Lasers
• Exhibit 4-1: Selected Clinical Studies on the Effectiveness of Phacoemulsification
• Exhibit 4-2: Selected Phacoemulsification Systems
• Exhibit 4-3: Selected Clinical Studies on the Effectiveness of Ophthalmic Laser Systems
• Exhibit 4-4: Selected Photocoagulating Laser Systems
• Exhibit 4-5: Selected Photodisrupting Laser Systems
• Exhibit 4-6: Selected Photoablating Laser Systems
• Exhibit 4-7: Selected Femtosecond Lasers
• Exhibit 4-8: Selected Multi-Modality Laser Systems

5. IMPLANTS AND DISPOSABLES
• 5.1. Intraocular Lenses
o 5.1.1. Clinical Results
o 5.1.2. Companies and Products
o 5.1.2.1. Monofocal Vs. Multifocal
o 5.1.2.2. Phakic vs. Aphakic IOLs
o 5.1.2.3. Other Types of IOLs
o 5.1.2.4. IOL Injectors or Insertion Instruments
o 5.1.2.5. Disposable Supplies and Accessories
• 5.2. Glaucoma Implants
o 5.2.1. Clinical Results
o 5.2.2. Companies and Products
• Exhibit 5-1: Selected Clinical Studies on the Effectiveness of IOL Implantation
• Exhibit 5-2: Selected Monofocal Intraocular Lenses
• Exhibit 5-3: Selected Multifocal Intraocular Lenses
• Exhibit 5-4: Selected Toric Intraocular Lenses
• Exhibit 5-5: Selected Accommodating Intraocular Lenses
• Exhibit 5-6: Selected Phakic Intraocular Lenses
• Exhibit 5-7: Selected Preloaded IOL Insertion Instruments
• Exhibit 5-8: Selected Disposable IOL Insertion Instruments
• Exhibit 5-9: Selected Reusable IOL Insertion Instruments
• Exhibit 5-10: Selected IOL Cartridges
• Exhibit 5-11: Selected Ophthalmic Viscoelastic Devices and Other Solutions
• Exhibit 5-12: Selected Supplies and Accessories
• Exhibit 5-13: Selected Clinical Studies on the Effectiveness of Glaucoma Implants
• Exhibit 5-14: Selected Glaucoma Implants
• Exhibit 5-15: Selected Glaucoma Supplies and Accessories

6. PROCEDURE VOLUMES AND MARKET FORECASTS
• 6.1. Global Procedure Volumes
• 6.2. Global Market Analysis
• 6.3. Competitive Analysis
• 6.4. Regional Analysis
o 6.4.1. The United States
o 6.4.1.1. Procedure Volumes
o 6.4.1.2. Market Analysis
o 6.4.1.3. Competitive Analysis
o 6.4.2. Europe
o 6.4.2.1. Procedure Volumes
o 6.4.2.2. Market Analysis
o 6.4.3. AP and ROW
o 6.4.3.1. Procedure Volumes
o 6.4.3.2. Market Analysis
o 6.4.3.3. OUS Competitive Analysis
• Exhibit 6-1: Global Burden of Blindness, Partial Sight, and Cataracts, 2009-2017
• Exhibit 6-2: Global Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017
• Exhibit 6-3: Cataract Procedure Volumes by Region, 2009-2017
• Exhibit 6-4: Refractive Eye Surgery, Procedure Volumes by Region, 2009-2017
• Exhibit 6-5: Global Market Forecast for Surgical Ophthalmology Products by Product Type, 2009-2017
• Exhibit 6-6: Global Market Forecast for Surgical Ophthalmology Products by Region, 2009-2017
• Exhibit 6-7: Global Supplier Shares, 2011 and 2012
• Exhibit 6-8: U.S. Burden of Blindness, Partial Sight, and Cataracts, 2009-2017
• Exhibit 6-9: U.S. Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017
• Exhibit 6-10: Cataract Procedure Volumes in the U.S., 2009-2017
• Exhibit 6-11: Refractive Surgery Volumes in the U.S., 2009-2017
• Exhibit 6-12: Phacoemulsification Procedure Volumes in the U.S., 2009-2017
• Exhibit 6-13: Cataract IOL Implantations in the U.S., 2009-2017
• Exhibit 6-14: Surgical Ophthalmology Products, U.S. Market Forecast, 2009-2017
• Exhibit 6-15: Ophthalmic Surgical Systems by Type, U.S. Market Forecast, 2009-2017
• Exhibit 6-16: U.S. Market Forecast for Phacoemulsification, 2009-2017
• Exhibit 6-17: U.S. Market Forecast for Phacoemulsification: Systems, Accessories, and Service, 2009-2017
• Exhibit 6-18: U.S. Market Forecast for Refractive Laser Systems, 2009-2017
• Exhibit 6-19: U.S. Market Forecast for Refractive Laser Systems: Systems, Accessories, and Service, 2009-2017
• Exhibit 6-20: U.S. Market Forecast for Licensing Fees Associated with Refractive Laser Systems, 2009-2017
• Exhibit 6-21: U.S. Market Forecast for Implants and Disposables by Type, 2009-2017
• Exhibit 6-22: U.S. Market Forecast for Cataract IOLs, 2009-2017
• Exhibit 6-23: U.S. Market Forecast for Ophthalmic Viscosurgical Devices, 2009-2017
• Exhibit 6-24: U.S. Market Forecast for Phakic IOLs, 2009-2017
• Exhibit 6-25: U.S. Market Forecast for Diagnostic Ophthalmic Systems, 2009-2017
• Exhibit 6-26: U.S. Supplier Shares for Cataract IOLs, 2011 and 2012
• Exhibit 6-27: U.S. Supplier Shares for Other Cataract Surgical Products, 2011 and 2012
• Exhibit 6-28: U.S. Supplier Shares for Refractive Surgery Products, 2011 and 2012
• Exhibit 6-29: U.S. Supplier Shares for Ophthalmic Diagnostic Systems, 2011 and 2012
• Exhibit 6-30: European Burden of Blindness, Partial Sight, and Cataracts, 2009-2017
• Exhibit 6-31: European Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017
• Exhibit 6-32: Cataract Procedure Volumes in Europe, 2009-2017
• Exhibit 6-33: Refractive Surgery Volumes in Europe, 2009-2017
• Exhibit 6-34: Phacoemulsification Procedure Volumes in Europe, 2009-2017
• Exhibit 6-35: Cataract IOL Implantations in Europe, 2009-2017
• Exhibit 6-36: Surgical Ophthalmology Products, European Market Forecast, 2009-2017
• Exhibit 6-37: Ophthalmic Surgical Systems by Type, European Market Forecast, 2009-2017
• Exhibit 6-38: European Market Forecast for Phacoemulsification, 2009-2017
• Exhibit 6-39: European Market Forecast for Phacoemulsification: Systems, Accessories, and Service, 2009-2017
• Exhibit 6-40: European Market Forecast for Refractive Laser Systems, 2009-2017
• Exhibit 6-41: European Market Forecast for Refractive Laser Systems: Systems, Accessories, and Service, 2009-2017
• Exhibit 6-42: European Market Forecast for Licensing Fees Associated with Refractive Laser Systems, 2009-2017
• Exhibit 6-43: European Market Forecast for Implants and Disposables by Type, 2009-2017
• Exhibit 6-44: European Market Forecast for Cataract IOLs, 2009-2017
• Exhibit 6-45: European Market Forecast for Ophthalmic Viscosurgical Devices, 2009-2017
• Exhibit 6-46: European Market Forecast for Phakic IOLs, 2009-2017
• Exhibit 6-47: European Market Forecast for Diagnostic Ophthalmic Systems, 2009-2017
• Exhibit 6-48: AP and ROW Burden of Blindness, Partial Sight, and Cataracts, 2009-2017
• Exhibit 6-49: AP and ROW Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017
• Exhibit 6-50: Cataract Procedure Volumes in AP and ROW, 2009-2017
• Exhibit 6-51: Refractive Surgery Volumes in AP and ROW, 2009-2017
• Exhibit 6-52: Phacoemulsification Procedure Volumes in AP and ROW, 2009-2017
• Exhibit 6-53: Cataract IOL Implantations in AP and ROW, 2009-2017
• Exhibit 6-54: Surgical Ophthalmology Products, AP and ROW Market Forecast, 2009-2017
• Exhibit 6-55: Ophthalmic Surgical Systems by Type, AP and ROW Market Forecast, 2009-2017
• Exhibit 6-56: AP and ROW Market Forecast for Phacoemulsification, 2009-2017
• Exhibit 6-57: AP and ROW Market Forecast for Phacoemulsification: Systems, Accessories, and Service, 2009-2017
• Exhibit 6-58: AP and ROW Market Forecast for Refractive Laser Systems, 2009-2017
• Exhibit 6-59: AP and ROW Market Forecast for Refractive Laser Systems: Systems, Accessories, and Service, 2009-2017
• Exhibit 6-60: AP and ROW Market Forecast for Licensing Fees Associated with Refractive Laser Systems, 2009-2017
• Exhibit 6-61: AP and ROW Market Forecast for Implants and Disposables by Type, 2009-2017
• Exhibit 6-62: AP and ROW Market Forecast for Cataract IOLs, 2009-2017
• Exhibit 6-63: AP and ROW Market Forecast for Ophthalmic Viscosurgical Devices, 2009-2017
• Exhibit 6-64: AP and ROW Market Forecast for Phakic IOLs, 2009-2017
• Exhibit 6-65: AP and ROW Market Forecast for Diagnostic Ophthalmic Systems, 2009-2017
• Exhibit 6-66: OUS Supplier Shares for Cataract IOLs, 2011 and 2012
• Exhibit 6-67: OUS Supplier Shares for Other Cataract Surgical Products, 2011 and 2012
• Exhibit 6-68: OUS Supplier Shares for Refractive Surgery Products, 2011 and 2012
• Exhibit 6-69: OUS Supplier Shares for Ophthalmic Diagnostic Systems, 2011 and 2012

7. COMPANY PROFILES
• 7.1. Abbott Medical Optics
• 7.2. Accutome
• 7.3. Alcon
• 7.4. Bausch and Lomb
• 7.5. Carl Zeiss Meditec
• 7.6. Dutch Ophthalmic Research Center (DORC) International BV
• 7.7. Ellex
• 7.8. Haag-Streit AG
• 7.9. Iridex Corporation
• 7.10. LensAR
• 7.11. Lumenis Vision
• 7.12. Nidek Company, Ltd.
• 7.13. Oertli Instruments AG
• 7.14. Ophtec BV
• 7.15. Optimedica
• 7.16. Quantel Medical
• 7.17. Staar Surgical
• 7.18. Technolas Perfect Vision
• 7.19. Topcon Medical Systems
• 7.20. Ziemer Ophthalmic Systems AG

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.